Renal dysfunction and CABG
Publication in refereed journal


Times Cited
Web of Science3WOS source URL (as at 17/09/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractRenal dysfunction after coronary artery bypass grafting is common and is associated with increased morbidity and mortality. A number of strategies with potential renoprotective effects have been investigated, but no single one has been found to warrant routine use in CABG except fenoldopam in which the data to date appear promising. Other measures such as avoidance of nephrotoxic agents, including recent radiocontrast for coronary angiography, may reduce the incidence of renal dysfunction after cardiac surgery and should be implemented in routine care, whenever possible. The best renal protection strategy remains the same as for other organ protection and consists of optimizing haemodynamics, oxygenation, metabolic states and hydration.
All Author(s) ListHo AMH, Chan SKC
Journal nameCurrent Opinion in Pharmacology
Year2012
Month4
Day1
Volume Number12
Issue Number2
PublisherElsevier
Pages181 - 188
ISSN1471-4892
eISSN1471-4973
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesPharmacology & Pharmacy; PHARMACOLOGY & PHARMACY

Last updated on 2020-18-09 at 00:41